Barbados vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy
Barbados
0 patients
in 2021
Montserrat
0 patients
in 2019
Barbados rank
141st
Montserrat rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Barbados
- Montserrat
How they compare
Barbados currently reports 0 patients against 0 patients in Montserrat, a difference of 0 patients.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Montserrat ahead.
Barbados ranks 141st and Montserrat ranks 141st of 183 countries.
Barbados has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Barbados | Montserrat | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 0.6667 patients | 0 patients | 0.6667 patients | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Barbados or Montserrat?
- Barbados, at 0 patients against 0 patients in Montserrat as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Barbados and Montserrat?
- 0 patients, with Barbados ahead.
- How many years of comparable data are there for Barbados and Montserrat?
- 10 years are reported by both, from 2009 to 2019.
- How do Barbados and Montserrat rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Barbados ranks 141st and Montserrat ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.